Breedervac-III-Plus

Bursal Disease-newcastle-bronchitis Vaccine

Standard And Variant,

Mass. Type

Killed Virus

Read In Full

Description

Breedervac-iii-plus Is Prepared Using Specific Pathogen Free (spf) Or Approved Substrates And Contains Newcastle Disease Virus, Infectious Bronchitis Disease Virus, And Standard, Gls, And Delaware (a And E) Strains Of Infectious Bursal Disease Virus, Inactivated And Suspended In The Aqueous Phase Of An Oil Adjuvant Emulsion.

indications For Use

Breedervac-iii-plus Is Indicated For The Vaccination Of Breeder Replacement Chickens Against Newcastle Disease, Infectious Bursal Disease, (standard; Delaware And Gls Variants), And Mass. Type Infectious Bronchitis. Chickens Should Be In Good Health When Vaccinated. Sick Or Weak Chickens Will Not Develop Adequate Immunity.

the Use Of Any Inactivated Vaccine May Cause False Positive Results On Mycoplasma Plate Tests. Avoid Mycoplasma Testing Prior To Ten Weeks Post-vaccination.

dosage And Administration

Allow the vaccine to reach ambient temperature 16-27°C (60-80°F), before use and shake vigorously before and periodically during use. Inject 0.5 mL intramuscularly or subcutaneously in chickens at least 3 weeks old, using an 18 gauge x 1/2" or 1/4" needle.

Vaccination Program

Although this vaccine can be used for primary vaccination at three weeks of age or older, available evidence suggests that the best protection is obtained when it is used for the revaccination of chickens previously immunized (primed) with the same type of live virus vaccines. Do not administer this vaccine during the critical laying period from onset until after peak production.

Example: Breeder chickens.

Primary vaccination with a live bursal disease vaccine (CLONEVAC-D78^® and/or PRIMEVAC IBD-3^®) on at least one occasion prior to 12 weeks of age.

Primary vaccination with a live Newcastle and bronchitis vaccines on at least two occasions prior to 12 weeks of age.

These primary vaccinations would then be followed by vaccination with BREEDERVAC-III-PLUS at 16-22 weeks of age. A minimum of four weeks should elapse between the last live virus priming and injection with BREEDERVAC-III-PLUS. Local conditions must be taken into consideration and, where necessary, veterinary advice should be sought.

Immunity

It is evident that for optimal protection, preceding vaccination with live vaccines (priming) should have taken place. Generally, in flocks vaccinated with BREEDERVAC-III-PLUS, a protective level of immunity will be achieved with only small variations between individual chickens. Revaccination during molt is recommended.

Vaccination Reaction

This vaccine does not provoke clinical reactions in chickens. If shock is observed, this must usually be ascribed to the stress of handling.

Storage Conditions

Store in the dark in a refrigerator between 2-7°C (35-45°F). DO NOT FREEZE OR EXPOSE TO DIRECT SUNLIGHT.

Precautions And Warnings

1. TO AVOID HUMAN INJECTION, EXTREME CAUTION SHOULD BE USED WHEN INJECTING ANY OIL EMULSION VACCINE. ACCIDENTAL HUMAN INJECTION MAY CAUSE SERIOUS LOCAL REACTIONS. CONTACT A PHYSICIAN IMMEDIATELY IF ACCIDENTAL HUMAN INJECTION OCCURS.

2. If it is desired to vaccinate birds during lay, a drop in egg production may occur.

3. Do not administer this vaccine during the critical egg laying period from onset until after peak production.

4. Vaccinate market chickens by subcutaneous route only.

5. Injection of inactivated vaccine into breast muscle may create processing plant problems under certain conditions.

6. Do not vaccinate chickens within 42 days before slaughter.

7. Do not mix this vaccine with any other substances.

8. Use entire contents when first opened.

9. Ensure that vaccination equipment is clean and sterile before use.

10. Do not use vaccination equipment with rubber parts, as the oil emulsion may attack certain types of rubber.

11. FOR VETERINARY USE ONLY.

Notice

This vaccine has undergone rigid potency, safety and purity tests, and meets Intervet Inc. and USDA requirements. It is designed to stimulate effective immunity when used as directed, but the user must be advised that the response to the product depends upon many factors, including, but not limited to, conditions of storage and handling by the user, administration of the vaccine, health and responsiveness of the individual chickens, and the degree of field exposure. Therefore, directions should be followed carefully.

This product is not hazardous when used according to directions supplied. A material safety data sheet (MSDS) is available upon request. This and any other consumer information can be obtained by calling Intervet Customer Service at 1-800-441-8272 or 1-302-934-8051.

Records

Keep a record of vaccine, quantity, serial number, expiration date, and place of purchase; the date and time of vaccination; the number, age, breed, and locations of chickens; names of operators performing the vaccination and any observed reactions.

How Supplied

The use of this vaccine is subject to applicable local and federal laws and regulations.

Use Only As Directed

Store Vaccine Between 2-7°c (35-45°f)

Do Not Freeze

This Product Is Non-returnable.

INTERVET INC., Millsboro, Delaware U.S.A.

U.S. Veterinary License No. 286

Made in U.S.A.

U.S. Patent Nos. 4,530,831, 5,064,646

Other Patents Pending

Intervet 11306

AL 131

Nac No.